Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Health Law and Policy (45)
- Agriculture Law (23)
- Law and Society (23)
- Environmental Law (21)
- International Law (20)
-
- Intellectual Property Law (18)
- Constitutional Law (17)
- Administrative Law (15)
- Human Rights Law (13)
- International Trade Law (13)
- Litigation (13)
- Natural Resources Law (13)
- State and Local Government Law (13)
- Energy and Utilities Law (12)
- Land Use Law (12)
- Public Law and Legal Theory (12)
- Science and Technology Law (12)
- Law of the Sea (11)
- Oil, Gas, and Mineral Law (11)
- Water Law (11)
- Legislation (10)
- Criminal Law (9)
- Social and Behavioral Sciences (9)
- Consumer Protection Law (7)
- Commercial Law (5)
- First Amendment (5)
- Medical Jurisprudence (5)
- Medicine and Health Sciences (5)
- Institution
-
- University of Arkansas, Fayetteville (20)
- American University Washington College of Law (14)
- Pace University (9)
- University of Michigan Law School (9)
- Georgia State University College of Law (6)
-
- Yeshiva University, Cardozo School of Law (5)
- Boston University School of Law (4)
- Brooklyn Law School (4)
- Seattle University School of Law (4)
- Mitchell Hamline School of Law (3)
- Northwestern Pritzker School of Law (3)
- University of Missouri School of Law (3)
- Vanderbilt University Law School (3)
- Washington and Lee University School of Law (3)
- California Western School of Law (2)
- Columbia Law School (2)
- Florida International University College of Law (2)
- Loyola University Chicago, School of Law (2)
- Roger Williams University (2)
- St. John's University School of Law (2)
- Texas A&M University School of Law (2)
- University of Georgia School of Law (2)
- University of South Carolina (2)
- University of Washington School of Law (2)
- William & Mary Law School (2)
- Chicago-Kent College of Law (1)
- Cleveland State University (1)
- DePaul University (1)
- Embry-Riddle Aeronautical University (1)
- Emory University School of Law (1)
- Keyword
-
- Drugs (13)
- Food policy (10)
- FDA (9)
- Food (9)
- Food regulation (9)
-
- Pharmaceuticals (8)
- Food and Drug Administration (7)
- Regulation (7)
- Agriculture (6)
- Food law (6)
- Public health (6)
- Controlled Substances Act (5)
- Farm Bill (4)
- Farmers (4)
- First Amendment (4)
- Generic drugs (4)
- Law (4)
- Medicine (4)
- Patents (4)
- Pharmaceutical (4)
- USDA (4)
- BSA (3)
- Bank Secrecy Act (3)
- Biologics (3)
- CSA (3)
- Climate change (3)
- Drug policy (3)
- Drug promotion (3)
- FDCA (3)
- Food security (3)
- Publication
-
- Journal of Food Law & Policy (19)
- Sustainable Development Law & Policy (11)
- Faculty Scholarship (9)
- Faculty Publications (8)
- Elisabeth Haub School of Law Faculty Publications (6)
-
- Georgia State University Law Review (5)
- Articles (4)
- Seattle University Law Review (4)
- Cardozo Law Review (3)
- Washington and Lee Law Review (3)
- American University Law Review (2)
- Cardozo Journal of Conflict Resolution (2)
- Columbia Center on Sustainable Investment Staff Publications (2)
- Cybaris® (2)
- Faculty Publications & Other Works (2)
- Georgia Journal of International & Comparative Law (2)
- Michigan Journal of Environmental & Administrative Law (2)
- Michigan Law Review (2)
- Northwestern Journal of Law & Social Policy (2)
- Pace Environmental Law Review (2)
- St. John's Law Review (2)
- Vanderbilt Journal of Transnational Law (2)
- Arkansas Law Review (1)
- Brooklyn Journal of International Law (1)
- Brooklyn Law Review (1)
- Buffalo Law Review (1)
- Catholic University Journal of Law and Technology (1)
- Chicago-Kent Law Review (1)
- DePaul Business & Commercial Law Journal (1)
- Faculty Articles (1)
- Publication Type
Articles 121 - 133 of 133
Full-Text Articles in Food and Drug Law
All Is Fair In Drugs And War: An Analysis Of "Pay-For-Delay" Agreements And Product Hopping, Sean Boyle
All Is Fair In Drugs And War: An Analysis Of "Pay-For-Delay" Agreements And Product Hopping, Sean Boyle
Valparaiso University Law Review
No abstract provided.
Union Co-Ops And The Revival Of Labor Law, Ariana R. Levinson
Union Co-Ops And The Revival Of Labor Law, Ariana R. Levinson
Cardozo Journal of Conflict Resolution
This article, as the first to identify and suggest solutions for the numerous labor law issues that must be addressed when establishing a union co-op, contributes to the existing literature on workerownership and cooperative economics. This article proceeds in four sections. The first section provides background about what union co-ops are, why unionization makes sense in the co-op setting, and the initiative to scale up union cooperatives. The second section, drawing on original interview data, provides background about the Cincinnati Union Co-op Initiative and Our Harvest, the first union worker-owned co-op that the Cincinnati Union Co-op Initiative incubated. The third …
Constructing A "Creative Reading": Will Us State Cannabis Legislation Threaten The Fate Of The International Drug Control Treaties?, Michael Tackeff
Constructing A "Creative Reading": Will Us State Cannabis Legislation Threaten The Fate Of The International Drug Control Treaties?, Michael Tackeff
Vanderbilt Journal of Transnational Law
While marijuana remains illegal at the federal level in the United States, state-level efforts to legalize cannabis have gained enormous momentum in recent years. The federal government, which possesses only limited power to stop this trend, has responded by grudgingly allowing such efforts to proceed, maintaining that its inaction on the issue comports with the international drug control regime. This presents a particularly complex problem for international policymakers and legal scholars, who worry that this state-federal conflict may render international drug treaties meaningless. This Note argues that the federal government's strategy is a productive lens through which to view an …
Pharming Out Data: A Proposal For Promoting Innovation And Public Health Through A Hybrid Clinical Data Protection Scheme, Lea M. Gulotta
Pharming Out Data: A Proposal For Promoting Innovation And Public Health Through A Hybrid Clinical Data Protection Scheme, Lea M. Gulotta
Vanderbilt Journal of Transnational Law
The pharmaceutical industry, one of the largest industries in the world, is rapidly becoming globalized. Clinical trials, which are required for drugs to be approved for human use, are increasingly performed outside of the pharmaceutical company's home country in an attempt to save money. This is mainly due to drug development's steep costs, and the high risks involved in an industry where only 12 percent of products that begin development ever make it to market. In order to help offset these risks and encourage innovation, many countries offer clinical trial data certain protections through patents, market exclusivity, or trade secret …
Utilizing Adr As A Vehicle For Effective Communication And Success Of Payment In Urgent Care, Stephanie R. Goldberg
Utilizing Adr As A Vehicle For Effective Communication And Success Of Payment In Urgent Care, Stephanie R. Goldberg
Cardozo Journal of Conflict Resolution
Section II of this Note provides background on urgent care and ADR. Section III will elaborate on current payment procedures and explain some of the pitfalls that create a need for a supplementary payment solution. Section IV lays out a four-step plan incorporating a logical progression of ADR techniques that would enable quality of care and ease and success of financial arrangements, and vastly improved patient-provider relations. The feasibility of this plan will be demonstrated through application of its steps to hypothetical examples, representative of various realistic patient experiences, in Section V. This plan is intended to aid the millions …
Administrative Guidance And Genetically Modified Food, Edward L. Rubin, Joanna K. Sax
Administrative Guidance And Genetically Modified Food, Edward L. Rubin, Joanna K. Sax
Faculty Scholarship
One of the most controversial issues in administrative law, the use of guidance, is exemplified by the regulation of one of the most controversial areas in modern society: genetically modified (GM) food. The appropriate use of guidance versus notice and comment rulemaking is a much-debated issue in administrative law. While agency officials generally assert that they are using guidance to express an agency’s thoughts about how to comply with a specific statutory provision or agency rule, the practical consequence is that the regulated party will hesitate to disobey, even if it believes that the guidance goes beyond the requirements of …
Guns N' Ganja: How Federalism Criminalizes The Lawful Use Of Marijuana, Ira P. Robbins
Guns N' Ganja: How Federalism Criminalizes The Lawful Use Of Marijuana, Ira P. Robbins
Scholarly Articles in Law Reviews & Journals
Federalism is a vital tenet of our Republic. Although federal law is the supreme law of the land, our Constitution recognizes the integral role that state law plays in the national scheme. Like any pharmaceutical drug that withstands rounds of clinical testing, state law functions as a laboratory in which Congress can evaluate and potentially adopt novel policies on a nation-wide basis. Most of the time, federal and state law exist harmoniously, complementing one another; other times, however, the two systems clash, striking a dissonant chord.
In the United States, state marijuana laws are currently on a crash course with …
The “Deeming Rule”: The Fda’S Destruction Of The Vaping Industry, Lauren H. Greenberg
The “Deeming Rule”: The Fda’S Destruction Of The Vaping Industry, Lauren H. Greenberg
Brooklyn Law Review
The FDA has recently passed sweeping regulations, which classifies and then regulates electronic cigarettes as “tobacco products” in the same manner as traditional cigarettes. Though the agency reasons that unknowing adults and children may easily turn to e-cigarettes without fully understanding the potential health effects, there is a lack of conclusive evidence in this field to justify such a comprehensive regulatory scheme. Through the far-reaching “Deeming Rule,” e-cigarette manufacturers are forced to comply with financially burdensome and time-consuming requirements before taking most of their products to market. The channels by which the FDA proposes manufacturers and retailers gain permission from …
Food Federalism: States, Local Governments, And The Fight For Food Sovereignty, Sarah B. Schindler
Food Federalism: States, Local Governments, And The Fight For Food Sovereignty, Sarah B. Schindler
Faculty Publications
Recently, a number of states have sought to withdraw or restrain local power. In this Article, which is part of the “Re-Thinking State Relevance” symposium hosted by the Ohio State Law Journal, I write about a state taking the opposite approach, and attempting to affirmatively endow its local governments with additional powers. The state is Maine, and the context is control over local food production and sales. This Article begins by addressing the emergence of the sustainable local foods movement broadly, and reasons for the growth of this movement. It then focuses more pointedly on the food sovereignty movement, considering …
Prescriptions At A Price: America's Opioid Crisis And The Increasing Toll On Drug Record Privacy, Reem Blaik
Prescriptions At A Price: America's Opioid Crisis And The Increasing Toll On Drug Record Privacy, Reem Blaik
Vanderbilt Journal of Entertainment & Technology Law
How should the US Constitution govern patient privacy in the face of a public health emergency? Declaring the United States' opioid crisis as a public health emergency may put the already-compromised integrity of drug record privacy at higher risk by virtue of emerging administrative responses, existing Supreme Court precedent, and acquiescent state laws. The White House convened a summit on opioids where the then-US attorney general discussed law enforcement responses to the crisis. Although the Fourth Amendment protects against unreasonable searches and seizures, the Supreme Court's third-party doctrine generally grants state and federal actors access to records released to third …
The History And Political Economy Of The Hatch-Waxman Amendments, Erika Lietzan
The History And Political Economy Of The Hatch-Waxman Amendments, Erika Lietzan
Faculty Publications
Reform of the Hatch–Waxman generic drug framework is in the air. Scholars, consumer advocacy groups, regulated industry, and policymakers are engaged in heated debate about perceived shortcomings in the scheme, flaws, and unexpected loopholes. Changes in how the U.S. Food and Drug Administration (FDA) implements the law, as well as changes to the law itself, are under serious consideration. These policymaking discussions take place against a backdrop of shared assumptions about the origins and nature of the original Hatch–Waxman legislation — assumptions that this Article claims are wrong. Convention wisdom holds that the Hatch–Waxman legislation was a delicate compromise privately …
Renovations Needed: The Fda's Floor/Ceiling Framework, Preemption, And The Opioid Epidemic, Michael R. Abrams
Renovations Needed: The Fda's Floor/Ceiling Framework, Preemption, And The Opioid Epidemic, Michael R. Abrams
Michigan Law Review
The FDA’s regulatory framework for pharmaceuticals uses a “floor/ceiling” model: administrative rules set a “floor” of minimum safety, while state tort liability sets a “ceiling” of maximum protection. This model emphasizes premarket scrutiny but largely relies on the state common law “ceiling” to police the postapproval drug market. As the Supreme Court increasingly holds state tort law preempted by federal administrative standards, the FDA’s framework becomes increasingly imbalanced. In the face of a historic prescription medication overdose crisis, the Opioid Epidemic, this imbalance allows the pharmaceutical industry to avoid internalizing the public health costs of their opioid products. This Note …
The Uneasy Case For Patent Law, Rachel E. Sachs
The Uneasy Case For Patent Law, Rachel E. Sachs
Michigan Law Review
A central tenet of patent law scholarship holds that if any scientific field truly needs patents to stimulate progress, it is pharmaceuticals. Patents are thought to be critical in encouraging pharmaceutical companies to develop and commercialize new therapies, due to the high costs of researching diseases, developing treatments, and bringing drugs through the complex, expensive approval process. Scholars and policymakers often point to patent law’s apparent success in the pharmaceutical industry to justify broader calls for more expansive patent rights.
This Article challenges this conventional wisdom about the centrality of patents to drug development by presenting a case study of …